Abstract 1829P
Background
To investigate the nutritional status of hospitalized patients with common malignant tumor in a cancer hospital of Southwest China.
Methods
From April 2017 to May 2021, we enrolled 891 patients with cancer hospitalized for treatment in Chongqing university Cancer Hospital. These patients were diagnosed with one of the following 16 different types of malignant tumors: lung cancer, gastric cancer, liver cancer, colorectal cancer, breast cancer, esophageal cancer, cervical cancer, endometrial cancer, nasopharyngeal carcinoma, malignant lymphoma, leukemia, pancreatic cancer, ovarian cancer, prostate cancer, bladder cancer and brain tumor. Patient-generated subjective global assessment (PG-SGA), anthropometric measurements, and laboratory examination were used to evaluate the nutritional risk or nutritional status.Cancer pain status were assessed with the Numerical Rating Scale (NRS). We also investigated the nutritional therapy of these cancer patients.
Results
According to the PG-SGA score, 48.7% (434/891) of the cancer patients were severe malnutrition (PG-SGA≥9), 31.2% (312/891) were moderate malnutrition (8≥PG-SGA≥4), 14.7% (131/891) were mild malnutrition (PG-SGA 2∼3), and only 5.4% (48/891) patients were no malnutrition (PG-SGA 0∼1). The rate of malnutrition for gastrointestinal cancer patients is higher than Nongastrointestinal cancer patients (67.3% vs. 44.6%, χ2=31.48, P <0.001). Multiple linear regression analysis, PG-SGA scores and body mass index (P<0.001), serum total protein(P<0.001), hemoglobin serum(P<0.001), albumin (P<0.001), prealbumin (P<0.001), calf circumference (left side, P=0.001) were correlated. Age(≥65 years), albumin(<40g/L), prealbumin (<150mg/L) and cancer pain (NRS≥4) are the risk factors of severe malnutrition. However, only 26.8% (200/746) of all the moderately and severely malnourished patients received nutritional therapy.
Conclusions
94.6% of the common malignant tumor patients enrolled in the present study were malnutrition. Nutritional therapy of malignant tumor patients with malnutrition is very low.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1895P - Higher modified Glasgow Prognostic Score in cancer patients at the Emergency Department is associated with an increased risk of hospital admissions
Presenter: Dominikus Huber
Session: Poster session 12
1896P - Importance of prompt medical oncologist (MO) consultation at the Emergency Department (ED): A prospective study in a tertiary hospital on 10,896 admissions in the first quarter of 2024
Presenter: Cristina Morelli
Session: Poster session 12
1897P - Time to access to diagnosis and treatment for lung cancer (LC): Experience within an Italian comprehensive cancer center
Presenter: Simone Nardin
Session: Poster session 12
1898P - Efficacy of virtual reality-based interventions in cancer-related symptom management in AYA's: A systematic review
Presenter: Nikolina Dodlek
Session: Poster session 12
1899P - Cannabinoids for cancer-associated symptoms: A systematic review and meta-analysis
Presenter: Ioana Creanga-Murariu
Session: Poster session 12
1900P - Seasonal impact on subcutaneous port infections among oncological patients
Presenter: David Kiesl
Session: Poster session 12
1901P - State of supportive care in oncology 2024: Tumor types, industry support, endpoints, and trial locations
Presenter: David Benjamin
Session: Poster session 12
1902P - Modified Delphi consensus on interventions for radiation dermatitis in breast cancer: A Canadian expert perspective
Presenter: Tarek Hijal
Session: Poster session 12
1904P - Factors and trends associated with alcohol intake in patients with breast cancer
Presenter: Sanjna Rajput
Session: Poster session 12
1905P - Impact of proactive callback in patients with solid tumors receiving systemic therapy: A meta-analysis
Presenter: Jacqueline Savill
Session: Poster session 12